CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
Da Hea Seo, Kyoung Hwa Ha, So Hun Kim, Dae Jung Kim
Endocrinol Metab. 2021;36(1):70-80.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2020.777

Excel Download

Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea
Endocrinology and Metabolism. 2021;36(1):70-80   Crossref logo
Link1 Link2 Link3

Real-world evaluation of adverse pregnancy outcomes in women with gestational diabetes mellitus in the German health care system
Primary Care Diabetes. 2020;14(6):633-638   Crossref logo
Link1 Link2

Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2016;Volume 9:347-353   Crossref logo
Link1 Link2

Teneligliptin: Heralding Change in Type 2 Diabetes
Journal of Diabetes Mellitus. 2016;06(02):113-131   Crossref logo
Link1 Link2 Link3

Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis
. 2020;   Crossref logo
Link1 Link2

Abstract #245: Cardiovascular Risks Difference Between Men and Women with Type 2 Diabetes Exposed to Sulfonylurea in Real-World Clinical Practice in Canada
Endocrine Practice. 2016;22:54   Crossref logo
Link1 Link2

Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes
Metabolism. 1998;47(6):637-643   Crossref logo
Link1 Link2

Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
Diabetes mellitus. 2020;22(5):467-472   Crossref logo
Link1 Link2

Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
Diabetes Therapy. 2020;11(10):2257-2268   Crossref logo
Link1 Link2 Link3

Pharmacoeconomic aspects of the use of sulfonylurea drugs in type 2 diabetes mellitus
Diabetes mellitus. 2011;14(3):111-112   Crossref logo
Link1 Link2